Orencia 125 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FJKWG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,035
Award facts
- Contract value 100% obligated
- $35,034.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $35,034.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Orencia 125 mg/mL syringes. The delivery order was issued on April 21, 2025, with an ultimate completion date of April 22, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively in defense procurement markets. The company's extensive portfolio of federal contract awards demonstrates expertise in delivering branded and generic prescription drugs, biologics, and specialty pharmaceutical products to military health facilities. Orencia, a biologic medication used primarily for treating autoimmune conditions, represents the type of specialized pharmaceutical product that supports the medical supply needs of DoD healthcare systems globally under this long-term contracting vehicle.
Quick answers
Who was awarded contract SPE2DB25FJKWG?
SPE2DB25FJKWG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 21, 2025.
How much is contract SPE2DB25FJKWG worth?
The government has obligated $35,035 on SPE2DB25FJKWG.
Is contract SPE2DB25FJKWG an order under another contract?
Yes. SPE2DB25FJKWG is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJKWG competed?
The extent of competition for SPE2DB25FJKWG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award